Kyntra Bio (KYNB) EBT (2014 - 2026)
Kyntra Bio (KYNB) posted EBT of -$15.1 million for Q1 2026, down 3.57% sequentially from -$14.6 million in Q4 2025, and up 9.74% YoY from -$13.8 million in Q1 2025.
Kyntra Bio (KYNB) EBT (2014 - 2026) Analysis & Trends
Kyntra Bio has reported EBT for 13 years, with the latest figure at -$15.1 million in Q1 2026.
- Quarterly EBT rose 9.74% year-over-year to -$15.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$56.7 million (up 53.21% YoY) and the FY2025 annual result came in at -$58.3 million, up 61.99% from the prior year.
- EBT slipped to -$15.1 million in Q1 2026 per KYNB's latest filing, from -$14.6 million in the prior quarter.
- Over five years, EBT peaked at -$8.7 million in Q4 2024 and troughed at -$93.1 million in Q4 2023.
- A 5-year average of -$49.7 million and a median of -$49.0 million in 2024 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2024: EBT sank 285.51% in 2022, then surged 90.7% in 2024.
- Over 5 years, EBT stood at -$66.3 million in 2022, then tumbled by 40.36% to -$93.1 million in 2023, then soared by 90.7% to -$8.7 million in 2024, then plunged by 68.65% to -$14.6 million in 2025, then slipped by 3.57% to -$15.1 million in 2026.
- According to Business Quant data, EBT over the past three periods registered -$15.1 million, -$14.6 million, and -$13.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 177.81 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -11.37 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 81.49 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -264.70 Mn |
| 10 | Kyntra Bio | 29.83 Mn | 29.83 Mn | 1.47 Mn | 11.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.97 Mn |
| Mar 31, 2026 | -15.13 Mn |
| Dec 31, 2025 | -14.61 Mn |
| Sep 30, 2025 | -13.15 Mn |
| Jun 30, 2025 | -13.78 Mn |
| Mar 31, 2025 | -16.76 Mn |
| Dec 31, 2024 | -8.66 Mn |
| Sep 30, 2024 | -48.29 Mn |
| Jun 30, 2024 | -47.38 Mn |
| Mar 31, 2024 | -49.04 Mn |
| Dec 31, 2023 | -93.12 Mn |
| Sep 30, 2023 | -64.21 Mn |
| Jun 30, 2023 | -88.47 Mn |
| Mar 31, 2023 | -77.43 Mn |
| Dec 31, 2022 | -66.35 Mn |
| Sep 30, 2022 | -91.94 Mn |
| Jun 30, 2022 | -73.17 Mn |
| Mar 31, 2022 | -63.41 Mn |
| Dec 31, 2021 | -134.31 Mn |
| Sep 30, 2021 | 49.56 Mn |